# Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy

> **NCT03835520** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Cliniques universitaires Saint-Luc- Université Catholique de Louvain** · enrollment: 200 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Immunotherapeutic Agent
- **DRUG:** Molecular Target

## Key facts

- **NCT ID:** NCT03835520
- **Lead sponsor:** Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-07-11
- **Primary completion:** 2028-05
- **Final completion:** 2028-05-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03835520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03835520, "Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03835520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*